- Home
- GLP vs DYN Comparison
GLP vs DYN Comparison
Compare GLP & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLP
- DYN
- Stock Information
- Founded
- GLP 2005
- DYN 1984
- Country
- GLP United States
- DYN United States
- Employees
- GLP N/A
- DYN N/A
- Industry
- GLP Oil Refining/Marketing
- DYN Medicinal Chemicals and Botanical Products
- Sector
- GLP Energy
- DYN Health Care
- Exchange
- GLP Nasdaq
- DYN Nasdaq
- Market Cap
- GLP 1.7B
- DYN 1.9B
- IPO Year
- GLP 2005
- DYN 2020
- Fundamental
- Price
- GLP $45.36
- DYN $23.55
- Analyst Decision
- GLP Hold
- DYN Strong Buy
- Analyst Count
- GLP 1
- DYN 14
- Target Price
- GLP $56.00
- DYN $34.93
- AVG Volume (30 Days)
- GLP 41.5K
- DYN 2.9M
- Earning Date
- GLP 11-07-2025
- DYN 10-28-2025
- Dividend Yield
- GLP 6.56%
- DYN N/A
- EPS Growth
- GLP N/A
- DYN N/A
- EPS
- GLP 2.60
- DYN N/A
- Revenue
- GLP $17,827,598,000.00
- DYN N/A
- Revenue This Year
- GLP $37.98
- DYN N/A
- Revenue Next Year
- GLP $28.27
- DYN N/A
- P/E Ratio
- GLP $17.58
- DYN N/A
- Revenue Growth
- GLP 3.74
- DYN N/A
- 52 Week Low
- GLP $43.20
- DYN $6.36
- 52 Week High
- GLP $60.00
- DYN $35.68
- Technical
- Relative Strength Index (RSI)
- GLP 43.50
- DYN 82.00
- Support Level
- GLP $44.98
- DYN $23.05
- Resistance Level
- GLP $46.37
- DYN $25.00
- Average True Range (ATR)
- GLP 1.17
- DYN 0.96
- MACD
- GLP 0.29
- DYN 0.88
- Stochastic Oscillator
- GLP 78.75
- DYN 89.69
About GLP Global Partners LP Common Units representing Limited Partner Interests
Global Partners LP is a limited partnership that acts as a midstream logistics and marketing company. It is mainly engaged in purchasing, selling, storing and logistics of transporting petroleum and related products. The company owns and operates and control terminal networks of refined petroleum products and renewable fuels in Massachusetts, Maine, Connecticut, Vermont, and other places. It distributes gasoline and gasoline blendstocks, distillates, residual oil, renewable fuels, crude oil, natural gas and propane to wholesalers, retailers and commercial customers. The company operates through three segments i.e. Wholesale, Gasoline Distribution and Station Operations and Commercial. It generates maximum revenue from the Wholesale segment.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.